Ahima Press :: Home

There has been important evidence from clinical trials that further supports and broadens the merits of risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease, including peripheral arterial disease, atherosclerotic aortic disease, and carotid artery disease. ................
................

In order to avoid copyright disputes, this page is only a partial summary.